Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: new data from CREDIBLE-CR with an updated meta-analysis

Available online 4 April 2024, 107167

Author links open overlay panel, , Section snippetsCompeting Interests

The authors declare no conflicts of interest beyond being employees of Shionogi.

Funding

This study was funded by Shionogi, B.V.

Ethical Approval

Not required

Sequence Information

Not applicable

Medical writing support

Medical writing support was provided by Nathan Price-Lloyd of Oxford PharmaGenesis, Oxford, UK, and was funded by Shionogi, B.V.

References (9)

There are more references available in the full text version of this article.

View original article

0 0 0 0 0 0 0

留言 (0)